In 2020, the S&P BSE Healthcare Index increased by 61%, the best performance in the sector of pharma as well as the benchmark Sensex barometer, which increased by 15%. Stocks in this sector have seen a phenomenal trend.
India contributes the second-largest share of the world’s pharmaceutical and biotech workforce. In 2019, the domestic pharmaceutical market turnover reached Rs 1.4 lakh crore ($20.03 billion), an increase of 9.8% compared to Rs 1.29 lakh crore ($18.12 billion) in the previous year.
Known as the world’s pharmacy, India currently holds a responsible share of the global market and is the world’s largest supplier of generics. The country has gained a foothold on the global stage with its innovative generic drugs and active pharmaceutical ingredients (API). It is accountable for about 30 percent by volume and about 10 percent by value generic market. Despite the growth in other fields, generics remain a large part of the market.
The pharmaceutical sector in India is expected to grow to $100 billion by 2025. Bulk drugs, intermediates, drug formulations, biologics, and Ayush, herbal and surgical products are part of Pharmaceutical exports. Of the 35 companies with a market capitalization of more than Rs 5,000 each, 15 were selected on the basis of the highest returns in 10 years.
